Browse

COMPARISON OF 89ZR-PANITUMUMAB PET/CT AND FDG-PET/CT FOR PREOPERATIVE IDENTIFICATION OF METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA

Imaging and Screening

Yu-Jin Lee, MD; Nynke S van den Berg, PhD; Marisa Hom, PhD; Heying Duan; Carmen Azevedo; Valentina Ferri; Brock Martin, MD; Roan Raymundo; Jessa Castillo; Bin Shen, PhD; Michael J Kaplan, MD; Alexander D Colevas, MD; Frederick Chin, PhD; Fred Baik, MD; Andrei Iagaru, MD; Eben L Rosenthal

Stanford University

BENEFIT OF ADJUVANT CHEMOTHERAPY IN SURGICALLY RESECTED, NEGATIVE MARGIN HEAD AND NECK CANCER WITH PATHOLOGICALLY CONFIRMED EXTRANODAL EXTENSION

Radiation / Adjuvant Treatment

Ghayoour Mir, DO; Gregory L Barinsky, PharmD; Roman Povolotskiy, MD; Soly Baredes, MD; Boris Paskhover, MD; Richard C Park, MD; Dylan F Roden, MD, MPH

Rutgers New Jersey Medical School

TRANSORAL ROBOTIC SURGERY (TORS) VERSUS PRIMARY RADIOTHERAPY IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: AN UPDATED COMPARATIVE SURVIVAL ANALYSIS USING A LARGE POPULATION DATABASE.

Oropharynx / HPV Related Disease

Mitchell Flagg; Bharat Panuganti, MD; Rohith Voora, BS; Joseph Califano, MD; Ryan Orosco, MD

UCSD School of Medicine

EXTRANODAL EXTENSION ON PRESENTATION, TREATMENT, AND OUTCOMES OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Oropharynx / HPV Related Disease

Neel Sangal, MD; Justin Shinn; Leila Mady, MD, MPH, PHD; David Shimunov, BA; Karthik Rajasekaran; Steven Cannady, MD; Ara Chalian, MD; Christopher H Rassekh, MD; Devraj Basu, MD; Jason Newman, MD; Gregory Weinstein, MD; Robert Brody, MD

Hospital of the University of Pennsylvania

OUTCOMES OF POSTSURGICAL P16+ OROPHARYNGEAL CARCINOMA WITH HIGH RISK FEATURES TREATED WITH ADJUVANT RADIATION VERSUS ADJUVANT CHEMORADIATION

Oropharynx / HPV Related Disease

Jordan B Fenlon, MD; Ryan J Hutten, MD; Chris R Weil, MD; Shane Lloyd, MD; Ying J Hitchcock, MD

Huntsman Cancer Institute - University of Utah Health

SUPRAHYOID AND LATERAL PHARYNGOTOMY FOR MANAGEMENT OF OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW AND THE MAYO CLINIC EXPERIENCE.

Oropharynx / HPV Related Disease

Joseph N Badaoui, MD; Linda X Yin, MD; Christine M Lohse, MS; Daniel L Price, MD; Jan L Kasperbauer, MD; Eric J Moore, MD; Daniel B Noel, MD; Kerry D Olsen, MD; Kathryn M Van Abel, MD

Mayo Clinic, Rochester, Minnesota

THE EFFECT OF SARCOPENIA ON ONCOLOGIC OUTCOMES OF PRIMARY SURGERY OR DEFINITIVE RADIATION THERAPY IN LOCALIZED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA

Oropharynx / HPV Related Disease

Brennan Olson; Jared Edwards; Lucas Stone; Angie Jiang; Xinxia Zhu; John Holland, MD; Ryan Li, MD; Peter Andersen, MD; Stephanie Krasnow, PhD; Daniel Marks, MD, PhD; Daniel Clayburgh, MD, PhD

OHSU

THE ROLE OF ADJUVANT CHEMOTHERAPY IN HIGH RISK HPV-POSITIVE OROPHARYNGEAL CANCER

Oropharynx / HPV Related Disease

Clifford Chang¹; Michelle Chen²; Steven B Chinn²

¹NYU School of Medicine; ²University of Michigan - Department of Otolaryngology - Head and Neck Surgery